朱雅茜

副教授 硕士生导师

所在单位:基础医学院

学历:博士研究生毕业

办公地点:湖南省长沙市岳麓区桐梓坡路172号中南大学湘雅医学院孝骞楼5楼病理生理学教研室

性别:女

联系方式:zhu_yaxi@csu.edu.cn

学位:医学博士学位

在职信息:在职

其他任职:湖南省病理生理学会理事,湖南省内分泌学专业委员会青年委员会委员

毕业院校:中南大学

学科:基础医学

曾获荣誉:

2022-09-30  当选:  湖南省“三尖”创新人才工程青年科技人才(荷尖)

当前位置: 中文主页 >> 论文成果

The role of MicroRNAs in tendon injury, repair, and related tissue engineering.

发布时间:2023-02-27

点击次数:

发表刊物:Biomaterials

关键字:Antiadhesion; Biomaterials; MicroRNAs (miRNAs); Tendon healing; Tendon injuries; Tissue engineering.

摘要:Tendon injuries are one of the most common musculoskeletal disorders that cause considerable morbidity and significantly compromise the patients' quality of life. The innate limited regenerative capacity of tendon poses a substantial treating challenge for clinicians. MicroRNAs (miRNAs) are a family of small non-coding RNAs that play a vital role in orchestrating many biological processes through post-transcriptional regulation. Increasing evidence reveals that miRNA-based therapeutics may serve as an innovative strategy for the treatment of tendon pathologies. In this review, we briefly present miRNA biogenesis, the role of miRNAs in tendon cell biology and their involvement in tendon injuries, followed by a summary of current miRNA-based approaches in tendon tissue engineering with a special focus on attenuating post-injury fibrosis. Next, we discuss the advantages of miRNA-functionalized scaffolds in achieving sustained and localized miRNA administration to minimize off-target effects, and thus hoping to inspire the development of effective miRNA delivery platforms specifically for tendon tissue engineering. We envision that advancement in miRNA-based therapeutics will herald a new era of tendon tissue engineering and pave a way for clinical translation for the treatments of tendon disorders.

合写作者:Zhu Y, Zhu W, Zhang G, Yang YP

第一作者:Liu Q

论文类型:期刊论文

通讯作者:Zhao C

期号:277

页面范围:121083

是否译文:

发表时间:2021-10-01

上一条: IL-1R1 blockade attenuates liver injury through inhibiting the recruitment of myeloid-derived suppressor cells in sepsis.

下一条: Targeted Derivation of Organotypic Glucose- and GLP-1-Responsive β Cells Prior to Transplantation into Diabetic Recipients.